Dupilumab in the Treatment of Cutaneous Lymphoid Hyperplasia
Australasian Journal of Dermatology · 2026-05 · 67 (3)
DOI: 10.1111/ajd.70075 ↗Kurz gefasst
Fallbericht in der Zeitschrift Australasian Journal of Dermatology, online erschienen am 05.03.2026. Verfasst von Georgia De'Ambrosis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Gold Coast Hospital and Health Service, Gold Coast, Queensland, Australia. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gold Coast Hospital and Health Service, Gold Coast, Queensland, Australia.
- The University of Queensland, Faculty of Health, Medicine and Behavioural Sciences, Brisbane, Queensland, Australia.
- Griffith University, School of Medicine and Dentistry, Gold Coast, Queensland, Australia.
- Sullivan Nicolaides Pathology, Brisbane, Queensland, Australia.
- Queensland Children's Hospital, Brisbane, Queensland, Australia.
ORCID-Profile: Georgia De'Ambrosis, Jessica Gartside, Laura Wheller
Zitieren
APA
De'Ambrosis, G., Gartside, J., van Aartsen, M., & Wheller, L. (2026). Dupilumab in the Treatment of Cutaneous Lymphoid Hyperplasia. Australasian Journal of Dermatology, 67(3). https://doi.org/10.1111/ajd.70075
Vancouver
De'Ambrosis G, Gartside J, van Aartsen M, Wheller L. Dupilumab in the Treatment of Cutaneous Lymphoid Hyperplasia. Australasian Journal of Dermatology. 2026;67(3). doi:10.1111/ajd.70075
BibTeX
@article{DeAmbrosis2026,
author = {De'Ambrosis, Georgia and Gartside, Jessica and van Aartsen, Margreth and Wheller, Laura},
title = {Dupilumab in the Treatment of Cutaneous Lymphoid Hyperplasia},
journal = {Australasian Journal of Dermatology},
year = {2026},
volume = {67},
number = {3},
doi = {10.1111/ajd.70075}
}
EUVIMED